Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial

Publication date: Available online 8 December 2020Source: The Lancet Respiratory MedicineAuthor(s): Tracey A Day, Adam Penn-Nicholson, Angelique Kany Kany Luabeya, Andrew Fiore-Gartland, Nelita Du Plessis, Andre G Loxton, Julie Vergara, Tom A Rolf, Tim D Reid, Asma Toefy, Justin Shenje, Hendrik Geldenhuys, Michele Tameris, Simbarashe Mabwe, Nicole Bilek, Linda-Gail Bekker, Andreas Diacon, Gerhard Walzl, Jill Ashman, Aude Frevol
Source: The Lancet Respiratory Medicine - Category: Respiratory Medicine Source Type: research